Menu Close

Arthritis At Home 222 – Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Arthritis At Home 222 – Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.

Additional learning resources

Arthritis At Home